• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰性长链非编码RNA HELLPAR或上调的微小RNA-448通过抑制ADAM10来抑制鼻咽癌进展。

Interfered long non-coding RNA HELLPAR or up-regulated microRNA-448 inhibits nasopharyngeal carcinoma progression via suppression of ADAM10.

作者信息

Zhu Wenjuan, Yang Qi, Yang Huijun, Qian Mingtao, Ji Yan, Liu Jianyong

机构信息

Otolaryngology Head and Neck Surgery, Zhangjiagang Hospital Affiliated to Soochow University (Zhang Jiagang First Peoples Hospital), No. 68, West Jiyang Road, Zhangjiagang, 215600, Jiangsu, China.

出版信息

Discov Oncol. 2025 May 21;16(1):849. doi: 10.1007/s12672-025-02565-5.

DOI:10.1007/s12672-025-02565-5
PMID:40397191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12095706/
Abstract

OBJECTIVE

Nasopharyngeal carcinoma (NPC) is a highly invasive malignancy with poor prognosis, necessitating further exploration of its molecular mechanisms. While HELLP-associated long non-coding RNA (HELLPAR), microRNA-448 (miR-448), and a disintegrin and metalloprotease 10 (ADAM10) have been implicated in other malignancies, their regulatory interplay and functional roles in NPC remain unclear. This study aimed to investigate the role of HELLPAR in NPC progression through its interaction with miR-448 and ADAM10.

METHODS

Cancerous and adjacent non-cancerous tissues were collected from 53 NPC patients admitted to our hospital between 1st January 2018 and 1st January 2020. Transcript levels of HELLPAR, miR-448, and ADAM10 were measured using quantitative real-time PCR (RT-qPCR), while the protein expression levels of ADAM10 were assessed by Western blotting. Long-term survival data were analyzed to assess the correlation between HELLPAR expression and patient prognosis. The binding interactions of HELLPAR/miR-448 and miR-448/ADAM10 were predicted and experimentally validated. Overexpression and knockdown constructs for HELLPAR, miR-448, and ADAM10 were transfected into NPC cells to assess their effects on proliferation, invasion, and apoptosis.

RESULTS

HELLPAR and ADAM10 were significantly upregulated at both the RNA and protein levels in NPC tissues and cells, while miR-448 was notably downregulated. Suppression of HELLPAR inhibited NPC cell proliferation and invasion while promoting apoptosis. Mechanistically, HELLPAR functioned as a competitive endogenous RNA (ceRNA) by binding to miR-448, thereby downregulating its RNA expression. Overexpression of miR-448 counteracted the tumor-promoting effects of HELLPAR. Additionally, miR-448 directly targeted and suppressed ADAM10. Overexpression of ADAM10 reversed the inhibitory effects of miR-448 on NPC cell proliferation and invasion.

CONCLUSION

The HELLPAR/miR-448/ADAM10 axis plays a critical role in NPC progression. Suppressing HELLPAR expression enhances miR-448 activity, which in turn downregulates ADAM10 at both RNA and protein levels, leading to reduced NPC cell proliferation and invasion while promoting apoptosis.

摘要

目的

鼻咽癌(NPC)是一种侵袭性很强且预后较差的恶性肿瘤,有必要进一步探究其分子机制。虽然HELLP相关长链非编码RNA(HELLPAR)、微小RNA-448(miR-448)和去整合素金属蛋白酶10(ADAM10)已被证明与其他恶性肿瘤有关,但其在鼻咽癌中的调控相互作用和功能作用仍不清楚。本研究旨在通过HELLPAR与miR-448和ADAM10的相互作用,探讨HELLPAR在鼻咽癌进展中的作用。

方法

收集2018年1月1日至2020年1月1日在我院收治的53例鼻咽癌患者的癌组织及癌旁非癌组织。采用定量实时PCR(RT-qPCR)检测HELLPAR、miR-448和ADAM10的转录水平,同时通过蛋白质印迹法评估ADAM10的蛋白表达水平。分析长期生存数据以评估HELLPAR表达与患者预后之间的相关性。预测并通过实验验证HELLPAR/miR-448和miR-448/ADAM10的结合相互作用。将HELLPAR、miR-448和ADAM10的过表达和敲低构建体转染到鼻咽癌细胞中,以评估它们对细胞增殖、侵袭和凋亡的影响。

结果

HELLPAR和ADAM10在鼻咽癌组织和细胞中的RNA和蛋白质水平均显著上调,而miR-448明显下调。抑制HELLPAR可抑制鼻咽癌细胞增殖和侵袭,并促进细胞凋亡。机制上,HELLPAR作为竞争性内源性RNA(ceRNA)与miR-448结合,从而下调其RNA表达。miR-448的过表达抵消了HELLPAR的促肿瘤作用。此外,miR-448直接靶向并抑制ADAM10。ADAM10的过表达逆转了miR-448对鼻咽癌细胞增殖和侵袭的抑制作用。

结论

HELLPAR/miR-448/ADAM10轴在鼻咽癌进展中起关键作用。抑制HELLPAR表达可增强miR-448活性,进而在RNA和蛋白质水平下调ADAM10,导致鼻咽癌细胞增殖和侵袭减少,同时促进细胞凋亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/12095706/6e228ebc43a4/12672_2025_2565_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/12095706/3b147123b86f/12672_2025_2565_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/12095706/acbd714c0d9f/12672_2025_2565_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/12095706/4f21275a0ab0/12672_2025_2565_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/12095706/cd099ac39fa5/12672_2025_2565_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/12095706/6e228ebc43a4/12672_2025_2565_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/12095706/3b147123b86f/12672_2025_2565_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/12095706/acbd714c0d9f/12672_2025_2565_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/12095706/4f21275a0ab0/12672_2025_2565_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/12095706/cd099ac39fa5/12672_2025_2565_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/12095706/6e228ebc43a4/12672_2025_2565_Fig5_HTML.jpg

相似文献

1
Interfered long non-coding RNA HELLPAR or up-regulated microRNA-448 inhibits nasopharyngeal carcinoma progression via suppression of ADAM10.干扰性长链非编码RNA HELLPAR或上调的微小RNA-448通过抑制ADAM10来抑制鼻咽癌进展。
Discov Oncol. 2025 May 21;16(1):849. doi: 10.1007/s12672-025-02565-5.
2
Long non-coding RNA PTPRG-AS1/microRNA-124-3p regulates radiosensitivity of nasopharyngeal carcinoma via the LIM Homeobox 2-dependent Notch pathway through competitive endogenous RNA mechanism.长链非编码 RNA PTPRG-AS1/微小 RNA-124-3p 通过竞争性内源性 RNA 机制调控 LIM 同源盒 2 依赖性 Notch 通路调节鼻咽癌的放射敏感性。
Bioengineered. 2022 Apr;13(4):8208-8225. doi: 10.1080/21655979.2022.2037364.
3
Down-regulated long non-coding RNA LHFPL3 antisense RNA 1 inhibits the radiotherapy resistance of nasopharyngeal carcinoma via modulating microRNA-143-5p/homeobox A6 axis.下调的长非编码 RNA LHFPL3 反义 RNA 1 通过调节 microRNA-143-5p/同源盒 A6 轴抑制鼻咽癌的放射抵抗。
Bioengineered. 2022 Mar;13(3):5421-5433. doi: 10.1080/21655979.2021.2024386.
4
MicroRNA-185 inhibits cell proliferation while promoting apoptosis and autophagy through negative regulation of TGF-β1/mTOR axis and HOXC6 in nasopharyngeal carcinoma.微小 RNA-185 通过负向调控 TGF-β1/mTOR 轴和 HOXC6 抑制鼻咽癌细胞增殖,促进细胞凋亡和自噬。
Cancer Biomark. 2018;23(1):107-123. doi: 10.3233/CBM-181459.
5
Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.AXL 的功能及其对鼻咽癌的调控的分子机制。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Jun 28;47(6):685-697. doi: 10.11817/j.issn.1672-7347.2022.210786.
6
Long noncoding RNA long intergenic non-protein-coding RNA 173 contributes to nasopharyngeal carcinoma progression by regulating microRNA-765/Gremlin 1 pathway.长非编码 RNA 长基因间非蛋白编码 RNA 173 通过调节 microRNA-765/Gremlin 1 通路促进鼻咽癌的进展。
Hum Exp Toxicol. 2023 Jan-Dec;42:9603271231172921. doi: 10.1177/09603271231172921.
7
Regulatory Mechanism of lncRNA CTBP1-AS2 in Nasopharyngeal Carcinoma Cell Proliferation and Apoptosis via the miR-140-5p/BMP2 Axis.长链非编码 RNA CTBP1-AS2 通过 miR-140-5p/BMP2 轴调控鼻咽癌细胞增殖和凋亡的机制研究。
Protein Pept Lett. 2022;29(7):621-630. doi: 10.2174/0929866529666220726151339.
8
MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.MALAT1/miR-124/Capn4 轴调控鼻咽癌细胞的增殖、侵袭和 EMT。
Cancer Biol Ther. 2017 Oct 3;18(10):792-800. doi: 10.1080/15384047.2017.1373214. Epub 2017 Aug 31.
9
miR-100 inhibits the migration and invasion of nasopharyngeal carcinoma by targeting IGF1R.微小RNA-100通过靶向胰岛素样生长因子1受体抑制鼻咽癌的迁移和侵袭。
Oncol Lett. 2018 Jun;15(6):8333-8338. doi: 10.3892/ol.2018.8420. Epub 2018 Apr 4.
10
LncRNA TP73-AS1 regulates miR-495 expression to promote migration and invasion of nasopharyngeal carcinoma cells through junctional adhesion molecule A.长链非编码 RNA TP73-AS1 通过连接黏附分子 A 调控 miR-495 的表达促进鼻咽癌细胞的迁移和侵袭。
Kaohsiung J Med Sci. 2021 May;37(5):361-370. doi: 10.1002/kjm2.12338. Epub 2021 Jan 5.

本文引用的文献

1
The emerging role of microRNA-based therapeutics in the treatment of preeclampsia.基于微小RNA的疗法在子痫前期治疗中的新兴作用。
Placenta. 2024 Dec;158:38-47. doi: 10.1016/j.placenta.2024.09.018. Epub 2024 Sep 30.
2
A Non-Canonical p75HER2 Signaling Pathway Underlying Trastuzumab Action and Resistance in Breast Cancer.一种非经典的 p75HER2 信号通路,该通路是曲妥珠单抗在乳腺癌中发挥作用和产生耐药性的基础。
Cells. 2024 Aug 29;13(17):1452. doi: 10.3390/cells13171452.
3
MicroRNA-510-3p regulated vascular dysfunction in Preeclampsia by targeting Vascular Endothelial Growth Factor A (VEGFA) and its signaling axis.
微小 RNA-510-3p 通过靶向血管内皮生长因子 A(VEGFA)及其信号轴调节子痫前期血管功能障碍。
Placenta. 2024 Aug;153:31-52. doi: 10.1016/j.placenta.2024.05.135. Epub 2024 May 27.
4
HELLPAR/RRM2 axis related to HMMR as novel prognostic biomarker in gliomas.HELLPAR/RRM2 轴与 HMMR 作为胶质瘤的新型预后生物标志物相关。
BMC Cancer. 2023 Feb 7;23(1):125. doi: 10.1186/s12885-023-10596-w.
5
Micro ribonucleic acid-448 regulates zinc finger e-box binding homeobox 1 to inhibit the growth of breast cancer cells and increase their sensitivity to chemotherapy.微小核糖核酸-448 通过调控锌指 E 盒结合同源盒 1 抑制乳腺癌细胞的生长并增加其对化疗的敏感性。
Clinics (Sao Paulo). 2022 Jul 26;77:100089. doi: 10.1016/j.clinsp.2022.100089. eCollection 2022.
6
Anticancer function of microRNA-30e is mediated by negative regulation of HELLPAR, a noncoding macroRNA, and genes involved in ubiquitination and cell cycle progression in prostate cancer.microRNA-30e 通过负调控非编码宏 RNA HELLPAR 及其参与泛素化和细胞周期进程的基因在前列腺癌中发挥抗癌作用。
Mol Oncol. 2022 Aug;16(16):2936-2958. doi: 10.1002/1878-0261.13255. Epub 2022 Jun 14.
7
Long non-coding RNAs in nasopharyngeal carcinoma: biological functions and clinical applications.长链非编码 RNA 在鼻咽癌中的作用:生物学功能及临床应用。
Mol Cell Biochem. 2021 Sep;476(9):3537-3550. doi: 10.1007/s11010-021-04176-4. Epub 2021 May 17.
8
Silencing lncRNA AGAP2-AS1 Upregulates miR-195-5p to Repress Migration and Invasion of EC Cells via the Decrease of FOSL1 Expression.沉默长链非编码RNA AGAP2-AS1通过降低FOSL1表达上调miR-195-5p以抑制内皮癌细胞的迁移和侵袭。
Mol Ther Nucleic Acids. 2020 Jun 5;20:331-344. doi: 10.1016/j.omtn.2019.12.036. Epub 2020 Jan 15.
9
The PGC-1α/NRF1/miR-378a axis protects vascular smooth muscle cells from FFA-induced proliferation, migration and inflammation in atherosclerosis.PGC-1α/NRF1/miR-378a 轴可防止动脉粥样硬化中脂肪酸诱导的血管平滑肌细胞增殖、迁移和炎症。
Atherosclerosis. 2020 Mar;297:136-145. doi: 10.1016/j.atherosclerosis.2020.02.001. Epub 2020 Feb 8.
10
The Prognostic Role of Programmed Death-Ligand 1 in Nasopharyngeal Carcinoma.程序性死亡配体 1 在鼻咽癌中的预后作用。
Laryngoscope. 2020 Nov;130(11):2598-2606. doi: 10.1002/lary.28523. Epub 2020 Feb 29.